Idera Pharmaceuticals Inc (NASDAQ:IDRA) declared positive top-line information from its randomized, twofold unseeing, controlled Phase 2 trial of IMO-8400 in 32 patients with moderate-to-serious plaque psoriasis. The required destination of the trial was to evaluate the safety and decency of IMO-8400 over a 12-week medication time, with an optional goal to assess the clinical performance of IMO-8400. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares after opening at $4.51 on last trade day and at the end of the day closed at $4.57. Company price to sales ratio in past twelve months was calculated as 4445.54 and price to cash ratio as 5.40. Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed a negative weekly performance of -24.84%.
TheStreet Ratings team rates Genco Shipping & Trading Limited (NYSE:GNK) as a Sell with a ratings score of D. Genco Shipping & Trading Limited (NYSE:GNK) shares advanced 18.18% in last trading session and ended the day on $1.69. GNK return on equity ratio is recorded as -22.10% and its return on assets is -7.90%. Genco Shipping & Trading Limited (NYSE:GNK) yearly performance is -32.40%.
TheStreet Ratings team rates Arotech Corporation (NASDAQ:ARTX) as a Hold with a ratings score of C. Arotech Corporation (NASDAQ:ARTX) shares moved up 7.18% in last trading session and was closed at $5.82, while trading in range of $5.27 – $6.24. Arotech Corporation (NASDAQ:ARTX) year to date (YTD) performance is 66.76%.
As previously reported, B. Riley downgraded The Wet Seal, Inc. (NASDAQ:WTSL) to Sell from Neutral. The firm downgraded shares citing weak Q1 guidance and potentially substantial dilution from the convert deal. Price target lowered to 50c from $2.10. The Wet Seal, Inc. (NASDAQ:WTSL) weekly performance is -18.06%. On last trading day company shares ended up $1.27. The Wet Seal, Inc. (NASDAQ:WTSL) distance from 50-day simple moving average (SMA50) is -35.27%. Analysts mean target price for the company is $3.02.
Leave a Reply